Ravinder Gogia1, Maxwell Binstock1, Ryutaro Hirose2, W John Boscardin3, Mary-Margaret Chren1, Sarah T Arron4. 1. Department of Dermatology, University of California at San Francisco, San Francisco, California. 2. Division of Transplantation, Department of Surgery, University of California at San Francisco, San Francisco, California. 3. Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California. 4. Department of Dermatology, University of California at San Francisco, San Francisco, California. Electronic address: arrons@derm.ucsf.edu.
Abstract
BACKGROUND: Solid organ transplant recipients (OTR) are at an increased risk of developing squamous cell carcinoma (SCC) of the skin after transplantation. In predominantly white cohorts, Fitzpatrick skin type (FST) has been reported to be a risk factor for developing posttransplantation skin cancers. OBJECTIVE: Our goal was to determine if FST is a statistically significant risk factor for the development of SCC after solid organ transplantation in a diverse US population of OTR. METHODS: A cohort of OTR completed a questionnaire of demographic factors, transplant type, FST, and skin cancer history. Univariate and multivariate analyses were performed to determine the risk factors for development of SCC after transplantation. RESULTS: As expected, male subjects had an increased risk for SCC compared with female subjects (P = .02), and those aged 50 years and older at the time of transplantation were more likely to develop SCC compared with those younger than 50 years (P < .001). The risk of SCC increased with each incremental decrease in FST, from FST VI to FST I (linear test for trend P < .001). LIMITATIONS: Our questionnaire did not ask specifically about immunosuppressive medications; instead, organ transplant category was used as a proxy for level of immunosuppression. CONCLUSIONS: FST, a patient-reported variable, is an independent risk factor for the development of SCC in OTR, and should be elicited from patients who have gone or will undergo organ transplantation.
BACKGROUND: Solid organ transplant recipients (OTR) are at an increased risk of developing squamous cell carcinoma (SCC) of the skin after transplantation. In predominantly white cohorts, Fitzpatrick skin type (FST) has been reported to be a risk factor for developing posttransplantation skin cancers. OBJECTIVE: Our goal was to determine if FST is a statistically significant risk factor for the development of SCC after solid organ transplantation in a diverse US population of OTR. METHODS: A cohort of OTR completed a questionnaire of demographic factors, transplant type, FST, and skin cancer history. Univariate and multivariate analyses were performed to determine the risk factors for development of SCC after transplantation. RESULTS: As expected, male subjects had an increased risk for SCC compared with female subjects (P = .02), and those aged 50 years and older at the time of transplantation were more likely to develop SCC compared with those younger than 50 years (P < .001). The risk of SCC increased with each incremental decrease in FST, from FST VI to FST I (linear test for trend P < .001). LIMITATIONS: Our questionnaire did not ask specifically about immunosuppressive medications; instead, organ transplant category was used as a proxy for level of immunosuppression. CONCLUSIONS: FST, a patient-reported variable, is an independent risk factor for the development of SCC in OTR, and should be elicited from patients who have gone or will undergo organ transplantation.
Authors: P Jensen; S Hansen; B Møller; T Leivestad; P Pfeffer; O Geiran; P Fauchald; S Simonsen Journal: J Am Acad Dermatol Date: 1999-02 Impact factor: 11.527
Authors: J N Bouwes Bavinck; B J Vermeer; F J van der Woude; J P Vandenbroucke; G M Schreuder; J Thorogood; G G Persijn; F H Claas Journal: N Engl J Med Date: 1991-09-19 Impact factor: 91.245
Authors: A España; P Redondo; A L Fernández; M Zabala; J Herreros; R Llorens; E Quintanilla Journal: J Am Acad Dermatol Date: 1995-03 Impact factor: 11.527
Authors: J K Robinson; Y Guevara; R Gaber; M L Clayman; M J Kwasny; J J Friedewald; E J Gordon Journal: Am J Transplant Date: 2014-11-13 Impact factor: 8.086
Authors: Daniel Ongaratto Barazzetti; Pedro Henrique Ongaratto Barazzetti; Bárbara Thomé Cavalheiro; Jorge Bins Ely; Daniel Holthausen Nunes; Ana Maria Nunes de Faria Stamm Journal: An Bras Dermatol Date: 2019-07-29 Impact factor: 1.896
Authors: Steven Y He; Charles E McCulloch; W John Boscardin; Mary-Margaret Chren; Eleni Linos; Sarah T Arron Journal: J Am Acad Dermatol Date: 2014-06-11 Impact factor: 11.527
Authors: Leila M Tolaymat; Danielle K Reimer; Joshua Feig; Melinda S Gillis; Leigh L Speicher; Claire B Haga; Emmanuel M Gabriel; Michael G Heckman; Mingyuan Yin; Scott W Fosko; Andrew P Keaveny; Nancy L Dawson Journal: Int J Dermatol Date: 2021-03-20 Impact factor: 2.736
Authors: Jeffrey F Scott; Kevin R Brough; Konstantin V Grigoryan; John G Muzic; Grace Y Kim; Rosalynn R Z Conic; Sheena T Hill; Jerry D Brewer; Christian L Baum; Mark R Litzow; William J Hogan; Mrinal S Patnaik; Shahrukh K Hashmi; Hillard M Lazarus; Jeremy S Bordeaux; Cheryl L Thompson; Meg R Gerstenblith; Julia S Lehman Journal: JAMA Dermatol Date: 2020-06-01 Impact factor: 10.282
Authors: Lee Wheless; Sarah Jacks; Kathryn Anne Mooneyham Potter; Brian C Leach; Joel Cook Journal: J Am Acad Dermatol Date: 2014-04-13 Impact factor: 11.527